TrialBMJ (Clinical research ed.)2023
Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.